
Find a Doctor

Shafeeq Ladha, MD, is a neurologist, the director of the Gregory W. Fulton ALS and Neuromuscular Disease Center, the Fulton Family Chair in Motor Neuron Disease, and a professor in the Department of Neurology at Barrow Neurological Institute.
Dr. Ladha received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University.
For more information or to request an appointment, please call (602) 406-6262.
- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial
Date: 04/2023
Authors: Priya S. Kishnani, Jordi Diaz-Manera, Antonio Toscano, Paula R. Clemens, Shafeeq Ladha, Shafeeq S. Ladha, Kenneth I. Berger, Hani Kushlaf, Volker Straub, Gerson Carvalho, Tahseen Mozaffar, Mark Roberts, Shahram Attarian, Yin-Hsiu Chien, Young-Chul Choi, John W. Day, Sevim Erdem-Ozdamar, Sergey Illarioshkin, Ozlem Goker-Alpan, Anna Kostera-Pruszczyk, Ans T. van der Ploeg, Kristina An Haack, Olivier Huynh-Ba, Swathi Tammireddy, Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Date: 06/2022
Authors: Samuel Arends, Judith Drenthen, Peter van den Bergh, Hessel Franssen, Robert D M Hadden, Badrul Islam, Satoshi Kuwabara, Ricardo C Reisin, Nortina Shahrizaila, Hiroshi Amino, Giovanni Antonini, Shahram Attarian, Claudia Balducci, Fabio Barroso, Tulio Bertorini, Davide Binda, Thomas H Brannagan, Jan Buermann, Carlos Casasnovas, Guido Cavaletti, Chi-Chao Chao, Mazen M Dimachkie, Ernesto A Fulgenzi, Giuliana Galassi, Gerardo Gutiérrez Gutiérrez, Thomas Harbo, Hans-Peter Hartung, Sung-Tsang Hsieh, Lynette Kiers, Helmar C Lehmann, Fiore Manganelli, Girolama A Marfia, Giorgia Mataluni, Julio Pardo, Yann Péréon, Yusuf A Rajabally, Lucio Santoro, Yukari Sekiguchi, Beth Stein, Mark Stettner, Antonino Uncini, Christine Verboon, Camiel Verhamme, Michal Vytopil, Waqar Waheed, Min Wang, Sasha Zivkovic, Bart C Jacobs, David R Cornblath, Shafeeq S. Ladha
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Date: 05/2022
Authors: Mazen M. Dimachkie, Richard J. Barohn, Barry Byrne, Ozlem Goker-Alpan, Priya S. Kishnani, Shafeeq Ladha, Shafeeq S. Ladha, Pascal Laforêt, Karl Eugen Mengel, Loren D. Peña, Sabrina Sacconi, Volker Straub, Jaya Trivedi, Philip Van Damme, Ans T. van der Ploeg, John Vissing, Peter Young, Kristina An Haack, Meredith Foster, Jane M. Gilbert, Patrick Miossec, Olivier Vitse, Tianyue Zhou, Benedikt Schoser
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
Date: 05/2022
Authors: Gopinath Krishnan, Denitza Raitcheva, Daniel Bartlett, Mercedes Prudencio, Diane M. McKenna-Yasek, Catherine Douthwright, Björn E. Oskarsson, Shafeeq Ladha, Shafeeq S. Ladha, Oliver D. King, Sami J. Barmada, Timothy M. Miller, Robert Bowser, Jonathan K. Watts, Leonard Petrucelli, Robert H. Brown, Mark W. Kankel, Fen-Biao Gao
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Date: 05/2022
Authors: Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Ayo Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry D. Heiman-Patterson, Carlayne Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq S. Ladha, Timothy M. Miller, Stephen N. Scelsa, Tuan H. Vu, Christina Fournier, Kristin M. Johnson, Andrea Swenson, Namita Goyal, Gary L. Pattee, Suma Babu, Marianne Chase
- English

- (602) 406-6262
- Fax: (602) 406-6261

Shafeeq Ladha, MD, is a neurologist, the director of the Gregory W. Fulton ALS and Neuromuscular Disease Center, the Fulton Family Chair in Motor Neuron Disease, and a professor in the Department of Neurology at Barrow Neurological Institute.
Dr. Ladha received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University.
For more information or to request an appointment, please call (602) 406-6262.

- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial
Date: 04/2023
Authors: Priya S. Kishnani, Jordi Diaz-Manera, Antonio Toscano, Paula R. Clemens, Shafeeq Ladha, Shafeeq S. Ladha, Kenneth I. Berger, Hani Kushlaf, Volker Straub, Gerson Carvalho, Tahseen Mozaffar, Mark Roberts, Shahram Attarian, Yin-Hsiu Chien, Young-Chul Choi, John W. Day, Sevim Erdem-Ozdamar, Sergey Illarioshkin, Ozlem Goker-Alpan, Anna Kostera-Pruszczyk, Ans T. van der Ploeg, Kristina An Haack, Olivier Huynh-Ba, Swathi Tammireddy, Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Date: 06/2022
Authors: Samuel Arends, Judith Drenthen, Peter van den Bergh, Hessel Franssen, Robert D M Hadden, Badrul Islam, Satoshi Kuwabara, Ricardo C Reisin, Nortina Shahrizaila, Hiroshi Amino, Giovanni Antonini, Shahram Attarian, Claudia Balducci, Fabio Barroso, Tulio Bertorini, Davide Binda, Thomas H Brannagan, Jan Buermann, Carlos Casasnovas, Guido Cavaletti, Chi-Chao Chao, Mazen M Dimachkie, Ernesto A Fulgenzi, Giuliana Galassi, Gerardo Gutiérrez Gutiérrez, Thomas Harbo, Hans-Peter Hartung, Sung-Tsang Hsieh, Lynette Kiers, Helmar C Lehmann, Fiore Manganelli, Girolama A Marfia, Giorgia Mataluni, Julio Pardo, Yann Péréon, Yusuf A Rajabally, Lucio Santoro, Yukari Sekiguchi, Beth Stein, Mark Stettner, Antonino Uncini, Christine Verboon, Camiel Verhamme, Michal Vytopil, Waqar Waheed, Min Wang, Sasha Zivkovic, Bart C Jacobs, David R Cornblath, Shafeeq S. Ladha
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Date: 05/2022
Authors: Mazen M. Dimachkie, Richard J. Barohn, Barry Byrne, Ozlem Goker-Alpan, Priya S. Kishnani, Shafeeq Ladha, Shafeeq S. Ladha, Pascal Laforêt, Karl Eugen Mengel, Loren D. Peña, Sabrina Sacconi, Volker Straub, Jaya Trivedi, Philip Van Damme, Ans T. van der Ploeg, John Vissing, Peter Young, Kristina An Haack, Meredith Foster, Jane M. Gilbert, Patrick Miossec, Olivier Vitse, Tianyue Zhou, Benedikt Schoser
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
Date: 05/2022
Authors: Gopinath Krishnan, Denitza Raitcheva, Daniel Bartlett, Mercedes Prudencio, Diane M. McKenna-Yasek, Catherine Douthwright, Björn E. Oskarsson, Shafeeq Ladha, Shafeeq S. Ladha, Oliver D. King, Sami J. Barmada, Timothy M. Miller, Robert Bowser, Jonathan K. Watts, Leonard Petrucelli, Robert H. Brown, Mark W. Kankel, Fen-Biao Gao
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Date: 05/2022
Authors: Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Ayo Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry D. Heiman-Patterson, Carlayne Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq S. Ladha, Timothy M. Miller, Stephen N. Scelsa, Tuan H. Vu, Christina Fournier, Kristin M. Johnson, Andrea Swenson, Namita Goyal, Gary L. Pattee, Suma Babu, Marianne Chase
- English